Design Therapeutics hints at ‘strategic realignment,’ replaces CEO; Karyopharm co-founder leads ATP’s Nereidnews2023-11-17T10:32:23+00:00November 17th, 2023|Endpoints News|
Music agency creates parody ‘Bravura’ drug ad to amplify its knack for pharma marketing scoresnews2023-11-16T20:00:25+00:00November 16th, 2023|Endpoints News|
Slew of House Democrats urge FDA, HHS to preserve access to misoprostol, methotrexatenews2023-11-16T19:38:06+00:00November 16th, 2023|Endpoints News|
Patient foundation accuses rare disease company Taysha of violating licensing agreementnews2023-11-16T19:26:01+00:00November 16th, 2023|Endpoints News|
‘Well underway’: FDA calls for faster confirmatory trials for accelerated approvalsnews2023-11-16T19:15:51+00:00November 16th, 2023|Endpoints News|
FDA’s Janet Woodcock to retire in early 2024news2023-11-16T18:57:09+00:00November 16th, 2023|Endpoints News|
Klick Health agency adds AI teams to accelerate pharma and healthcare marketing projectsnews2023-11-16T18:38:53+00:00November 16th, 2023|Endpoints News|
Sandoz opens two new facilities; Gates Foundation funds needle-free vaccines; Novartis expands Japanese sitenews2023-11-16T16:21:41+00:00November 16th, 2023|Endpoints News|
Biotech’s IPO outlook for the rest of the year sours in wake of war, broader industry strugglesnews2023-11-16T15:33:24+00:00November 16th, 2023|Endpoints News|
SpringWorks eyes US filing for MEK inhibitor after positive PhIIb data in rare diseasenews2023-11-16T15:22:53+00:00November 16th, 2023|Endpoints News|
